SUMO, Ubiquitin, UBL proteins: Implications for human diseases-fifth international conference

Brian Skaug; Zhijian J. Chen

SUMO, Ubiquitin, UBL proteins: Implications for human diseases-fifth international conference

Research output: Contribution to journal › Article

Abstract

The fifth international conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases, held in Houston, included topics covering the latest advances and new targets in the field of protein modification. This conference report highlights selected presentations on the structural characterization of ubiquitination and SUMOylation machinery; the regulation of ubiquitination enzymes, including E3 ligases; the functions and mechanism of action of SUMO-targeted ubiquitin ligases (STUbLs); the regulation of gene expression by SUMO; non-degradative functions of ubiquitin and SUMO in signal transduction; mechanisms and functions of ISG15 conjugation; the interaction of pathogens with host cell SUMOylation machinery; and stabilization of the Axin protein. Investigational drugs discussed include MLN-4924 (Millennium Pharmaceuticals Inc).

Original language	English (US)
Pages (from-to)	224-227
Number of pages	4
Journal	IDrugs
Volume	13
Issue number	4
State	Published - Apr 1 2010

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

Fingerprint Dive into the research topics of 'SUMO, Ubiquitin, UBL proteins: Implications for human diseases-fifth international conference'. Together they form a unique fingerprint.

Cite this

Skaug, B., & Chen, Z. J. (2010). SUMO, Ubiquitin, UBL proteins: Implications for human diseases-fifth international conference. IDrugs, 13(4), 224-227.

@article{b224ee67bf0840a193026fb535b2579a,

title = "SUMO, Ubiquitin, UBL proteins: Implications for human diseases-fifth international conference",

abstract = "The fifth international conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases, held in Houston, included topics covering the latest advances and new targets in the field of protein modification. This conference report highlights selected presentations on the structural characterization of ubiquitination and SUMOylation machinery; the regulation of ubiquitination enzymes, including E3 ligases; the functions and mechanism of action of SUMO-targeted ubiquitin ligases (STUbLs); the regulation of gene expression by SUMO; non-degradative functions of ubiquitin and SUMO in signal transduction; mechanisms and functions of ISG15 conjugation; the interaction of pathogens with host cell SUMOylation machinery; and stabilization of the Axin protein. Investigational drugs discussed include MLN-4924 (Millennium Pharmaceuticals Inc).",

author = "Brian Skaug and Chen, {Zhijian J.}",

year = "2010",

month = apr,

day = "1",

language = "English (US)",

volume = "13",

pages = "224--227",

journal = "IDrugs : the investigational drugs journal",

issn = "1369-7056",

publisher = "Current Drugs Ltd.",

number = "4",

}

TY - JOUR

T1 - SUMO, Ubiquitin, UBL proteins

T2 - Implications for human diseases-fifth international conference

AU - Skaug, Brian

AU - Chen, Zhijian J.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The fifth international conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases, held in Houston, included topics covering the latest advances and new targets in the field of protein modification. This conference report highlights selected presentations on the structural characterization of ubiquitination and SUMOylation machinery; the regulation of ubiquitination enzymes, including E3 ligases; the functions and mechanism of action of SUMO-targeted ubiquitin ligases (STUbLs); the regulation of gene expression by SUMO; non-degradative functions of ubiquitin and SUMO in signal transduction; mechanisms and functions of ISG15 conjugation; the interaction of pathogens with host cell SUMOylation machinery; and stabilization of the Axin protein. Investigational drugs discussed include MLN-4924 (Millennium Pharmaceuticals Inc).

AB - The fifth international conference on SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases, held in Houston, included topics covering the latest advances and new targets in the field of protein modification. This conference report highlights selected presentations on the structural characterization of ubiquitination and SUMOylation machinery; the regulation of ubiquitination enzymes, including E3 ligases; the functions and mechanism of action of SUMO-targeted ubiquitin ligases (STUbLs); the regulation of gene expression by SUMO; non-degradative functions of ubiquitin and SUMO in signal transduction; mechanisms and functions of ISG15 conjugation; the interaction of pathogens with host cell SUMOylation machinery; and stabilization of the Axin protein. Investigational drugs discussed include MLN-4924 (Millennium Pharmaceuticals Inc).

UR - http://www.scopus.com/inward/record.url?scp=77950195990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950195990&partnerID=8YFLogxK

M3 - Article

C2 - 20373248

AN - SCOPUS:77950195990

VL - 13

SP - 224

EP - 227

JO - IDrugs : the investigational drugs journal

JF - IDrugs : the investigational drugs journal

SN - 1369-7056

IS - 4

ER -